titanium has been researched along with Coronary Restenosis in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 18 (72.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, Y; Cho, KH; Han, X; Hong, YJ; Hyun, DY; Jeong, MH; Kim, J; Kim, JH; Kim, M; Kim, MC; Park, DS; Park, JK; Sim, DS | 1 |
| Cherian, AM; Joseph, J; Menon, D; Nair, MB; Nair, SV; Vijayakumar, M | 1 |
| Aguilera, MC; Alfonso, F; Antuña, P; Diego, G; Rivero, F; Rodríguez, D | 1 |
| Bae, IH; Hong, YJ; Jang, EJ; Jeong, MH; Kim, HB; Lee, SY; Lim, HC; Lim, KS; Park, DS; Park, JK; Shim, JW; Sim, DS | 1 |
| Gu, Z; Rolfe, BE; Thomas, AC; Xu, ZP | 1 |
| Karjalainen, PP; Kervinen, K; Lalmand, J; Mikkelsson, J; Nammas, W; Pentikäinen, M; Pietilä, M; Rivero-Crespo, F; Romppanen, H; Tedjokusumo, P | 1 |
| Ahn, Y; Bae, IH; Cho, DL; Hong, YJ; Jeong, HY; Jeong, MH; Kim, HS; Kim, JH; Kim, JM; Kim, YS; Lim, KS; Park, DS; Park, JK; Park, KH; Sim, DS; Song, SJ; Yang, EJ | 1 |
| Brugaletta, S; Sabaté, M | 1 |
| Díaz-Fernández, J; Doncel-Vecino, LJ; Fernández-Díaz, JA; López-Mínguez, JR; Martínez-Romero, P; Merchán-Herrera, A; Moreu-Burgos, J; Nogales-Asensio, JM; Pomar-Domingo, F; Valdesuso-Aguilar, R | 1 |
| Chen, X; Huo, Y; Li, H; Li, W; Li, Z; Lu, C; Lu, Q; Lyu, S; Song, X; Wang, D; Wang, L; Xu, B; Yuan, F; Zhang, Z | 1 |
| Cook, S; Garachemani, A; Jüni, P; Limacher, A; Meier, B; Moschovitis, A; Pilgrim, T; Räber, L; Stauffer, JC; Wenaweser, P; Windecker, S | 1 |
| Colkesen, EB; Eefting, FD; Karjalainen, PP; Rensing, BJ; Suttorp, MJ; Ten Berg, JM; Van Der Heyden, JA | 1 |
| Coviello, V; Dario, P; Filippeschi, C; La Motta, C; Menciassi, A; Piazza, V; Pingue, P; Ricotti, L; Sartini, S; Vannozzi, L | 1 |
| de Belder, A; de Bruyne, B; Karjalainen, PP; Nammas, W; Niemelä, M; Pietilä, M; Rivero-Crespo, F; Sia, J | 1 |
| Ahn, Y; Bae, IH; Hong, YJ; Hyun, DY; Jeong, MH; Kang, JC; Kim, JH; Lee, JH; Lim, KS; Park, DS; Sim, DS; Yang, HY; Zhehao, P | 1 |
| Airaksinen, JK; Karjalainen, PP; Laine, M; Nammas, W; Niemelä, M; Ylitalo, A | 1 |
| Huang, N; Li, Z; Yang, K; Zhang, B; Zhang, H; Zhao, A; Zhao, H | 1 |
| Balducelli, M; Bortone, AS; Colombo, A; Di Sciascio, G; Hehrlein, C; Kastrati, A; Moccetti, T; Waltenberger, J | 1 |
| Airaksinen, JK; Karjalainen, PP; Nammas, W; Ylitalo, A | 2 |
| Coraux, C; Debry, C; Dupret, A; Lavalle, P; Vautier, D; Vrana, NE | 1 |
| Airaksinen, KE; Karjalainen, PP; Lehtinen, T; Ylitalo, A | 1 |
| Chazin-Caldie, M; Goldberg, S; Kandzari, DE; Schwartz, RS; Sketch, MH | 1 |
| Alonso, J; Melero, JM; Olalla, E; Porras, C; Such, M | 1 |
| Aoki, J; Hara, K; Higashikuni, Y; Nakajima, H; Nakazawa, G; Ohtsuki, S; Onuma, Y; Tanabe, K; Yachi, S; Yagishita, A; Yamamoto, H | 1 |
1 review(s) available for titanium and Coronary Restenosis
| Article | Year |
|---|---|
Restenosis treatments using nanoparticle-based drug delivery systems.
Topics: Animals; Coronary Restenosis; Drug Delivery Systems; Drug Design; Humans; Liposomes; Nanoparticles; Nanotubes; Polymers; Proteins; Titanium | 2013 |
8 trial(s) available for titanium and Coronary Restenosis
| Article | Year |
|---|---|
A randomized study to compare bioactive titanium stents and everolimus-eluting stents in diabetic patients (TITANIC XV): 1-year results.
Topics: Aged; Coronary Restenosis; Diabetes Complications; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Sirolimus; Stents; Titanium | 2014 |
Novel completed biodegradable polymer sirolimus-eluting stent versus durable polymer sirolimus-eluting stent in de novo lesions: nine-month angiographic and three-year clinical outcomes of HOPE trial.
Topics: Adult; Aged; Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Middle Aged; Percutaneous Coronary Intervention; Polymers; Sirolimus; Titanium; Treatment Outcome; Young Adult | 2014 |
Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation.
Topics: Aged; Antibiotics, Antineoplastic; Cardiovascular Diseases; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Proportional Hazards Models; Reoperation; Sirolimus; Titanium; Treatment Outcome | 2015 |
TIDES-ACS Trial: comparison of titanium-nitride-oxide coated bio-active-stent to the drug (everolimus)-eluting stent in acute coronary syndrome. Study design and objectives.
Topics: Acute Coronary Syndrome; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Finland; France; Humans; Netherlands; Prospective Studies; Research Design; Stents; Titanium | 2015 |
4-Year outcome of bioactive stents versus everolimus-eluting stents in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Antineoplastic Agents; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prosthesis Design; Titanium; Treatment Outcome | 2016 |
A European multicentre, randomised study of the MAR-Tyn cobalt chromium tin-coated stent in patients with de novo coronary artery lesions: study design and protocol.
Topics: Angioplasty, Balloon, Coronary; Chromium Alloys; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Therapy, Combination; Europe; Humans; Kaplan-Meier Estimate; Logistic Models; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Research Design; Risk Assessment; Risk Factors; Stents; Thrombosis; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome | 2010 |
Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Endothelial Cells; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Stents; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy.
Topics: Aged; Angioplasty, Balloon, Coronary; Chromates; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Hypersensitivity; Immunosuppressive Agents; Male; Manganese; Metals; Middle Aged; Molybdenum; Nickel; Patch Tests; Sirolimus; Titanium; Treatment Outcome; Tunica Intima | 2008 |
16 other study(ies) available for titanium and Coronary Restenosis
| Article | Year |
|---|---|
Preclinical Evaluation of a Novel Polymer-free Everolimus-eluting Stent in a Mid-term Porcine Coronary Restenosis Model.
Topics: Animals; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Drug Evaluation, Preclinical; Drug-Eluting Stents; Everolimus; Polymers; Swine; Swine, Miniature; Titanium; Tomography, Optical Coherence | 2021 |
Coupled benefits of nanotopography and titania surface chemistry in fostering endothelialization and reducing in-stent restenosis in coronary stents.
Topics: Animals; Coronary Restenosis; Drug-Eluting Stents; Polymers; Rabbits; Stents; Titanium | 2022 |
Very Late Stent Thrombosis of a Titanium-Nitride-Oxide-Coated Bioactive Stent Resulting From Neoatherosclerosis: Optical Coherence Tomography Insights.
Topics: Coronary Restenosis; Humans; Neointima; Percutaneous Coronary Intervention; Stents; Thrombosis; Titanium; Tomography, Optical Coherence | 2020 |
In vitro and in vivo evaluation of a novel polymer-free everolimus-eluting stent by nitrogen-doped titanium dioxide film deposition.
Topics: Animals; Cell Proliferation; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Everolimus; Myocytes, Smooth Muscle; Nitrogen; Platelet Adhesiveness; Platelet Aggregation; Polymers; Spectroscopy, Fourier Transform Infrared; Surface Properties; Sus scrofa; Titanium; Tomography, Optical Coherence | 2018 |
Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Coated Materials, Biocompatible; Combined Modality Therapy; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Heart Diseases; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Sirolimus; Titanium; Treatment Outcome | 2013 |
Effect of polymer-free TiO2 stent coated with abciximab or alpha lipoic acid in porcine coronary restenosis model.
Topics: Abciximab; Animals; Antibodies, Monoclonal; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Fibrin; Hyperplasia; Immunoglobulin Fab Fragments; Inflammation; Male; Neointima; Percutaneous Coronary Intervention; Polymers; Swine; Thioctic Acid; Time Factors; Titanium; Treatment Outcome | 2014 |
Nitric-oxide coated bioactive titanium stents: safer and more effective than second-generation drug-eluting stents?
Topics: Coronary Restenosis; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Sirolimus; Stents; Titanium | 2014 |
Nanostructured ultra-thin patches for ultrasound-modulated delivery of anti-restenotic drug.
Topics: Barium Compounds; Cardiovascular Agents; Cell Adhesion; Cells, Cultured; Coronary Restenosis; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Muscle, Smooth, Vascular; Nanoparticles; Nanostructures; Polyesters; Polymers; Pyridines; Pyrimidinones; Titanium; Ultrasonics | 2016 |
A novel polymer-free drug-eluting stent coated with everolimus using nitrogen-doped titanium dioxide film deposition in a porcine coronary restenosis model.
Topics: Animals; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Everolimus; Nitrogen; Polymers; Prosthesis Design; Random Allocation; Swine; Titanium | 2016 |
Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial).
Topics: Acute Coronary Syndrome; Aged; Antineoplastic Agents; Case-Control Studies; Coronary Restenosis; Dilatation; Drug-Eluting Stents; Everolimus; Female; Heart Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Stents; Titanium | 2017 |
[Anti-restenosis study on a new drug eluting stent].
Topics: Angioplasty, Balloon, Coronary; Animals; Coated Materials, Biocompatible; Coronary Restenosis; Drug-Eluting Stents; Random Allocation; Swine; Swine, Miniature; Titanium | 2008 |
Titanium-nitride-oxide-coated Titan-2 bioactive coronary stent: a new horizon for coronary intervention.
Topics: Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Restenosis; Humans; Stents; Titanium | 2010 |
Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stent implantation in a real-world population: a comparison with paclitaxel-eluting stents: the PORI registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Confidence Intervals; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Finland; Humans; Male; Middle Aged; Odds Ratio; Paclitaxel; Propensity Score; Prospective Studies; Registries; Time Factors; Titanium; Treatment Outcome | 2011 |
Hybrid titanium/biodegradable polymer implants with an hierarchical pore structure as a means to control selective cell movement.
Topics: 3T3 Cells; Animals; Biocompatible Materials; Biodegradation, Environmental; Cell Movement; Cell Proliferation; Coronary Restenosis; Epithelial Cells; Humans; Materials Testing; Mice; Nanostructures; Polymers; Porosity; Prostheses and Implants; Surface Properties; Titanium | 2011 |
Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry.
Topics: Aged; Alloys; Analysis of Variance; Arteriosclerosis; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Female; Humans; Male; Nickel; Prospective Studies; Prosthesis Design; Saphenous Vein; Stents; Survival Rate; Titanium; Treatment Failure | 2003 |
Severe stenosis of anastomoses by using the symmetry aortic connector system.
Topics: Aged; Angina, Unstable; Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Coronary Restenosis; Equipment Design; Female; Humans; Hyperplasia; Male; Nickel; Reoperation; Saphenous Vein; Thoracic Arteries; Ticlopidine; Titanium; Tunica Intima; Ultrasonography | 2004 |